Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Rejnmark
Peter Vestergaard
Lene Heickendorff
Frederik Andreasen
Leif Mosekilde

Showing results (1-10 of 735) with videos related to

Pageof 74
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 16, 2005
Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanideLars Rejnmark, Peter Vestergaard, Lene Heickendorff, et al.
European Journal of Endocrinology|May 1, 2002
Diurnal rhythm of plasma 1,25-dihydroxyvitamin D and vitamin D-binding protein in postmenopausal women: relationship to plasma parathyroid hormone and calcium and phosphate metabolismLars Rejnmark, Anna L Lauridsen, Peter Vestergaard, et al.
Clinical Endocrinology|November 3, 2010
Determinants of plasma PTH and their implication for defining a reference intervalLars Rejnmark, Peter Vestergaard, Lene Heickendorff, et al.
European Journal of Endocrinology|March 26, 2008
Plasma 1,25(OH)2D levels decrease in postmenopausal women with hypovitaminosis DLars Rejnmark, Peter Vestergaard, Lene Heickendorff, et al.
International Journal of Endocrinology|December 18, 2009
Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trialLars Rejnmark, Peter Vestergaard, Lene Heickendorff, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 8, 2004
Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic womenLars Rejnmark, Niels Henrik Buus, Peter Vestergaard, et al.
Calcified Tissue International|September 24, 2010
Effects of smoking on severity of disease in primary hyperparathyroidismAnne Kristine Amstrup, Lars Rejnmark, Peter Vestergaard, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 2009
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control studyLars Rejnmark, Anna Tietze, Peter Vestergaard, et al.
Langenbeck'S Archives of Surgery|November 8, 2012
BMD improvements after operation for primary hyperparathyroidismLars Rolighed, Peter Vestergaard, Lene Heickendorff, et al.
European Journal of Endocrinology|February 4, 2015
No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism: results from a randomized controlled trialLars Rolighed, Lars Rejnmark, Tanja Sikjaer, et al.
Pageof 74

Showing results (1-10 of 735) with videos related to

Sort By:
Pageof 74
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 16, 2005
Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanideLars Rejnmark, Peter Vestergaard, Lene Heickendorff, et al.
European Journal of Endocrinology|May 1, 2002
Diurnal rhythm of plasma 1,25-dihydroxyvitamin D and vitamin D-binding protein in postmenopausal women: relationship to plasma parathyroid hormone and calcium and phosphate metabolismLars Rejnmark, Anna L Lauridsen, Peter Vestergaard, et al.
Clinical Endocrinology|November 3, 2010
Determinants of plasma PTH and their implication for defining a reference intervalLars Rejnmark, Peter Vestergaard, Lene Heickendorff, et al.
European Journal of Endocrinology|March 26, 2008
Plasma 1,25(OH)2D levels decrease in postmenopausal women with hypovitaminosis DLars Rejnmark, Peter Vestergaard, Lene Heickendorff, et al.
International Journal of Endocrinology|December 18, 2009
Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trialLars Rejnmark, Peter Vestergaard, Lene Heickendorff, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 8, 2004
Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic womenLars Rejnmark, Niels Henrik Buus, Peter Vestergaard, et al.
Calcified Tissue International|September 24, 2010
Effects of smoking on severity of disease in primary hyperparathyroidismAnne Kristine Amstrup, Lars Rejnmark, Peter Vestergaard, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 2009
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control studyLars Rejnmark, Anna Tietze, Peter Vestergaard, et al.
Langenbeck'S Archives of Surgery|November 8, 2012
BMD improvements after operation for primary hyperparathyroidismLars Rolighed, Peter Vestergaard, Lene Heickendorff, et al.
European Journal of Endocrinology|February 4, 2015
No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism: results from a randomized controlled trialLars Rolighed, Lars Rejnmark, Tanja Sikjaer, et al.
Pageof 74